InvestorsObserver
×
News Home

Where Does FibroGen Inc (FGEN) Stock Fall in the Biotechnology Field After It Has Fallen -4.54% This Week?

Monday, November 28, 2022 02:22 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does FibroGen Inc (FGEN) Stock Fall in the Biotechnology Field After It Has Fallen -4.54% This Week?

A rating of 83 puts FibroGen Inc (FGEN) near the top of the Biotechnology industry according to InvestorsObserver. FibroGen Inc's score of 83 means it scores higher than 83% of stocks in the industry. FibroGen Inc also received an overall rating of 67, putting it above 67% of all stocks. Biotechnology is ranked 54 out of the 148 industries.

Overall Score - 67
FGEN has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on FGEN!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With FibroGen Inc Stock Today?

FibroGen Inc (FGEN) stock has risen 0.22% while the S&P 500 has fallen -1.49% as of 2:19 PM on Monday, Nov 28. FGEN has risen $0.03 from the previous closing price of $13.85 on volume of 720,254 shares. Over the past year the S&P 500 has fallen -14.80% while FGEN has risen 15.47%. FGEN lost -$3.88 per share the over the last 12 months. Click Here to get the full Stock Report for FibroGen Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App